167
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 567-579 | Published online: 27 Apr 2022

References

  • Franklin JM, Schneeweiss S. When and how can real world data analyses substitute for randomized controlled trials? Clin Pharmacol Ther. 2017;102(6):924–933. doi:10.1002/cpt.857
  • Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials. 2015;16:495. doi:10.1186/s13063-015-1023-4
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-00004
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619. doi:10.1016/0895-4356(92)90133-8
  • Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–1079. doi:10.1016/0895-4356(93)90103-8
  • D’Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993;32(5):382–387. doi:10.1055/s-0038-1634956
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi:10.1093/aje/kwq433
  • van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–633. doi:10.1097/MLR.0b013e31819432e5
  • Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86–94. doi:10.1111/j.1742-7843.2009.00494.x
  • Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018;392(10148):685–697. doi:10.1016/S0140-6736(18)31311-4
  • Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–1505. doi:10.1016/S1470-2045(19
  • Butala NM, Johnson BK, Dziura JD, et al. Decade-long trends in mortality among patients with and without diabetes at a major academic medical center. JAMA Intern Med. 2014;174(7):1187–1188. doi:10.1001/jamainternmed.2014.1803
  • Wettermark B, Zoëga H, Furu K, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research–a literature review. Pharmacoepidemiol Drug Saf. 2013;22(7):691–699. doi:10.1002/pds.3457
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. CLEP. 2019;11:563–591. doi:10.2147/CLEP.S179083
  • Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;2015:7:449—490. doi:10.2147/CLEP.S91125
  • Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798–798f. doi:10.1093/ije/dyw213
  • WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health. Guidelines for ATC Classification and DDD Assignment 2020. WHO Collaborating Centre for Drug Statistics Methodology; 2019. Available from: www.whocc.no.Accessed April 9, 2022.
  • Hvidberg MF, Johnsen SP, Glümer C, Petersen KD, Olesen AV, Ehlers L. Catalog of 199 register-based definitions of chronic conditions. Scand J Public Health. 2016;44(5):462–479. doi:10.1177/1403494816641553
  • Mehta HB, Mehta V, Girman CJ, Adhikari D, Johnson ML. Regression coefficient–based scoring system should be used to assign weights to the risk index. J Clin Epidemiol. 2016;79:22–28. doi:10.1016/j.jclinepi.2016.03.031
  • Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128–138. doi:10.1097/EDE.0b013e3181c30fb2
  • Lemeshow S, Sturdivant RX, Hosmer DW Jr, Hosmer DW Jr. Applied Logistic Regression. 3rd ed. John Wiley & Sons; 2013.
  • Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):77. doi:10.1186/1471-2105-12-77
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. doi:10.2307/2531595
  • StataCorp. ci — Confidence Intervals for Means, Proportions, and Variances. In: Stata 17 Base Reference Manual. Stata Press; 2021.
  • StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021. Available From: https://www.stata.com/. Accessed April 9, 2022.
  • R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2021. Available from: https://www.R-project.org/. Accessed April 9, 2022.
  • RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA: RStudio, Inc.; 2021. Available from: http://www.rstudio.com/. Accessed April 9, 2022.
  • Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29(5):891–898. doi:10.1093/ije/29.5.891
  • Pottegård A, Olesen M, Christensen B, Christensen MB, Hallas J, Rasmussen L. Who prescribes drugs to patients: a Danish register‐based study. Br J Clin Pharmacol. 2021;87(7):2982–2987. doi:10.1111/bcp.14691
  • Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749–759. doi:10.1016/j.jclinepi.2010.10.004
  • Yurkovich M, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D. A systematic review identifies valid comorbidity indices derived from administrative health data. J Clin Epidemiol. 2015;68(1):3–14. doi:10.1016/j.jclinepi.2014.09.010
  • Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson comorbidity index and elixhauser score work. Med Care. 2015;53(9):e65–e72. doi:10.1097/MLR.0b013e318297429c